Jennie A. Buchanan, MD

• Fellow, Medical Toxicology
• Rocky Mountain Poison & Drug Center
• Denver, Colorado
• Formerly, Chief Resident
• Denver Health Residency in Emergency Medicine
• Denver, Colorado

Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics blood pressure chart readings for ages indapamide 1.5 mg otc. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system pulse pressure explained indapamide 2.5 mg amex. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B blood pressure medication guidelines generic 1.5 mg indapamide mastercard, interaction with cyclosporin A arteria intestinalis discount indapamide 2.5 mg fast delivery, and correlation between therapeutic response and itraconazole concentrations in plasma heart attack zippo indapamide 1.5 mg purchase online. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose-dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Pharmacokinetics of acyclovir in immunocompromised children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Mortality and costs of acute renal failure associated with amphotericin B therapy. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Management of indwelling central venous catheters in pediatric cancer patients with fever and neutropenia. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. The diagnosis of sinusitis in infants and children: x-ray, computed tomography, and magnetic resonance imaging. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a casecontrol observational study of 27 recent cases. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Approaches to management of invasive fungal infections in patients with hematologic malignancies. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Aspergillosis: the most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

A solitary parathyroid adenoma is most likely pulse pressure nhs generic indapamide 2.5 mg buy line, followed by parathyroid hyperplasia arrhythmia questions 1.5 mg indapamide order overnight delivery. Nevertheless hypertension nursing care plan 2.5 mg indapamide sale, for vanity reasons blood pressure ratio buy indapamide 2.5 mg, she elects to have it removed; the in situ gross appearance is shown blood pressure ranges pediatrics order on line indapamide. This large irregular and invasive retroperitoneal mass has a low-density attenuation with focal inhomogeneity that is suggestive of hemorrhage or necrosis. Sarcomas tend to arise in deep soft tissues, where they can reach substantial size before detection and thus can be difficult to completely resect. More indolent sarcomas often recur; more aggressive sarcomas (as marked histologically by mitotic index and areas of necrosis) have a poor prognosis. This well-demarcated and uniformly yellow mass is a lipoma, which is one of the most common benign neoplasms; these can be found in virtually any location. Most well-differentiated benign neoplasms are composed of cells that resemble the normal cell of origin. The original lesion may have been an "atypical" or pleomorphic lipoma or even a well-differentiated liposarcoma. Radiography reveals densely sclerotic bone in these areas, which would appear histologically as shown. Osteosclerosis along with osteolysis indicates the mixed phase of Paget disease of bone. The initial phase is osteolytic; this is followed by the mixed phase, and it ultimately evolves into the sclerotic ("burnt out") phase. One percent of all patients and 10% of patients with the polyostotic form can develop a sarcoma at an affected site. The dense mosaic of bone with irregular cement lines seen with H&E stain, with lamellae running in all directions under polarized light, is characteristic for Paget disease. The Paget bone is expanded but weaker, and it leads to secondary osteoarthritis as a result of abnormal joint alignment. Increased bone remodeling leads to increased vascularity and increased blood flow, thereby potentially causing high-output congestive heart failure. The nerve distal to the injury has vacuoles that are filled with axonal and myelin fragments. Axonotmesis is axonal loss without damage to the nerve sheath; Wallerian degeneration occurs, but the regrowing axon has an intact path to follow. Neurotmesis is the disruption or transection of the entire nerve so that regrowth cannot occur unless the cut ends are carefully realigned. The microscopic appearance of the common peroneal nerve distal to this site would appear as shown. There is recurrent demyelination and remyelination with an "onion bulb" appearance as a result of layering by Schwann cells in response to injury. There would be denervation atrophy followed by type grouping with reenervation; subsequent reinjury would lead to group atrophy. Guillain-Barré syndrome is an acute inflammatory neuropathy that often follows an influenza-like infection. Note the variations in the size of the muscle fibers and the markedly diminished dystrophin. This is a different mutation of the dystrophin gene than that seen with Duchenne muscular dystrophy; there is diminished (or dysfunctional) dystrophin, but it is not absent. The onset of the disease is delayed into adult life, and symptoms typically progress more slowly. Additional myopathic changes seen in striated muscle include the degeneration and regeneration of muscle fibers. The microscopic appearance of his muscle biopsy specimen with immunohistochemical staining for dystrophin is shown. Dystrophin is absent; it is responsible for linking sarcomeric contraction to the extracellular matrix. This is an X-linked disorder; one third to one half of cases represent new spontaneous mutations. Female carriers may exhibit mild weakness and some elevation in their creatine kinase levels; they also may develop dilated cardiomyopathy later in life. Muscle with inflammation is progressively replaced by fat and fibrous connective tissue. Death from progressive muscular weakness, which eventually affects the diaphragm and the myocardium, often occurs by age 20. Chains of central nuclei are seen in this longitudinal section, with fibrous replacement of the muscle fibers. Why are individuals in his family affected at an earlier age and more severely in successive generations The histology is confirmatory, showing a ragged red fiber with subsarcolemmal aggregates of mitochondria. With electron microscopy, these often show characteristic paracrystalline "parking lot" inclusions in the cristae. Her serum creatine kinase level is elevated, and her muscle biopsy specimen is shown. There is variation in fiber size and fibrous replacement, which is typical for a myopathic disease. Filamentous inclusions that contain amyloid and hyperphosphorylated tau proteins are seen. Intracellular -amyloid deposits, amyloid fibrils, and hyperphosphorylated tau suggest an aging phenomenon. There is marked lymphocytic infiltration with necrosis as well as the regeneration of muscle fibers. She has no focal neurologic signs, but she cannot remember three objects after 5 minutes, and she cannot count backward from 100 by 7s. She falls and sustains a hip fracture; subsequently, she dies of a pulmonary embolism. What neurodegenerative condition would involve a vertical gaze palsy and truncal rigidity A characteristic but nondiagnostic radiographic feature of dementias is cortical atrophy, which is shown here as prominently involving the frontal and parietal regions. The clinical history and severity of the atrophy suggest a form of frontotemporal lobar degeneration known as Pick disease. Tau filaments accumulate within Pick bodies; the latter are round to oval inclusions found in residual neurons. What paired helical filaments are present in round cytoplasmic inclusions in patients with this disorder The gross and clinical findings suggest a frontotemporal dementia such as Pick disease. Any condition that reduces or alters consciousness, including any condition that reduces the gag reflex, increases the risk of aspiration pneumonia. Progressive supranuclear palsy with neuronal loss in the globus pallidus, colliculi, and periaqueductal gray is present. In contrast with Pick disease, mutations in tau proteins have not been identified with this type of condition. Less than 20% of patients with epidural hematoma exhibit a "lucid" interval after injury. Unless the blood is expeditiously evacuated, the expanding hematoma within the closed intracranial cavity can cause herniation. He initially loses consciousness, but he then remains alert (albeit with a bad headache) for 2 hours, when he again becomes unconscious. At that time, his pulse is 55 beats/min, his respiratory rate is 10 breaths/min, and his blood pressure is 160/100 mm Hg. The large, lens-shaped epidural collection of blood on the left is bounded by parietal bone suture lines. The middle meningeal artery can be torn in association with a skull trauma, with or without fracture. Plaques of demyelination appear as pale tan to gray areas as compared with normal white matter. This is putatively an autoimmune disorder that involves cellular immunity directed against the oligodendroglial cells responsible for synthesizing myelin. The oligoclonal antibodies reflect increased B-cell proliferation, but these immunoglobulins are directed against multiple epitopes rather than myelin or other oligodendroglial antigens. Her newer symptoms are attributable to transverse myelitis (bladder and bowel dysfunction). Cerebellar findings (ataxia), intranuclear ophthalmoplegia, and sensory paresthesias are also common. Most patients have a relapsing-remitting course with acute exacerbations followed by partial to full remissions; one third of patients have complete recovery within 2 months of onset. This is a highly cellular neoplasm with vascular proliferation and densely packed malignant cells arranged around areas of necrosis (pseudopalisading). The large right cerebral mass infiltrates across the midline and impinges on the cerebral ventricles. Because it is difficult to eradicate such large neoplasms surgically, most patients survive less than 1 year. This meningioma is composed of whorled nests of cells with abundant pink cytoplasm (psammoma bodies may also be seen in this kind of neoplasm). She has also developed obsessive anxiety about her health and her children, and she is calling the school that they attend several times per day. If she had other similar lesions and an acoustic neuroma, what syndrome would you suspect There is a circumscribed mass in the parasagittal region that is impinging on the frontal lobe; this is consistent with meningioma. Meningiomas often express progesterone receptors, so their growth is stimulated during menstrual cycles or pregnancy. Most are benign lesions; approximately 10% are atypical (having more aggressive growth) or frankly malignant. Neurologic examination shows impairment of his attention span, verbal and nonverbal memory, spatial skills, and judgment. Sporadic Creutzfeldt-Jakob disease has an incidence of 1 in 1 million, with a mean age at onset of 62 years and survival of less than 1 year. The rarer variant CreutzfeldtJakob disease is presumed to be related to bovine spongiform encephalopathy, which has a mean age at onset of 28 years and a longer course. He is no longer able to perform any activities of daily living, and he exhibits myoclonic jerks of his entire body whenever anyone touches him. This is spongiform encephalopathy with numerous clear vacuolar spaces in the neocortex, which is consistent with Creutzfeldt-Jakob disease. The accumulated abnormal protein drives the loss of neuronal cell function, vacuolization, and death, thereby leading to the extensive and rapid destruction of the brain. In the United States, 20% of strokes are intracerebral hemorrhages; most of these result from hypertension, and most occur in the basal ganglia and the thalamus. Intracerebral hemorrhage accounts for approximately 15% of mortality in patients with chronic hypertension. A large hemorrhage can cause obstructive hydrocephalus by compressing the foramen of Monro, the third ventricle, or the aqueduct of Sylvius. He develops bilateral "blown" pupils and becomes unresponsive, dying within 1 hour. The bright attenuation is in the right basal ganglia ; this is consistent with hypertensive hemorrhage. With chronic hypertension, smaller penetrating cerebral arteries undergo hyaline arteriosclerosis and subintimal fibroblast proliferation, ultimately leading to wall weakening; focal Charcot-Bouchard microaneurysms can also occur. The prognosis for hemorrhages in the basal ganglia, thalamus, and brainstem is poor. There is a focus of abnormal ectatic venous channels with intervening gliotic tissue ; this is consistent with an arteriovenous malformation. Other vascular malformations include cavernous hemangiomas, which lack intervening nervous tissue, and capillary telangiectasias, which have ectatic thin-walled vessels with interspersed neural tissue. He is treated via the endovascular injection of acrylic material to thrombose the lesion. A representative microscopic appearance of what his brain lesion could look like is shown. There is a focal area that consists of irregular vascular channels, which is consistent with a vascular malformation. The most common site of this condition is the territory of the middle cerebral artery. The abnormal vasculature associated with this malformation has a tendency to bleed within the brain or to extend into the subarachnoid space. There is extensive subarachnoid hemorrhage, particularly at the base of the brain in the vicinity of the circle of Willis and tracking up over the left convexity. It is likely that bleeding has occurred as a result of the rupture of a saccular (berry) aneurysm. What might you think about if the clinical history also included adult-onset renal failure Note a large saccular (berry) aneurysm at the branching of the basilar artery into the posterior cerebral arteries. Although these are considered congenital, most are not present at birth; rather, they develop with time as a result of focal vascular wall weakness. Adult polycystic kidney disease, EhlersDanlos syndrome, Marfan syndrome, neurofibromatosis, aortic coarctation, and fibromuscular dysplasia are associated conditions. Note a posterior occipital skull fracture with soft-tissue swelling at the occiput as a result of blunt force trauma. The moving skull striking an object transmits the force to the opposite side, which results in a contrecoup injury such as subfrontal or temporal tip contusions. Falls in older individuals who have cerebral atrophy are more prone to the tearing of cerebral veins and subsequent subdural hematoma from the venous bleeding.

Sibling Adaptation to Childhood Cancer Collaborative Study: the association of sibling adaptation with maternal well-being blood pressure patch buy genuine indapamide on-line, physical health blood pressure 7550 indapamide 2.5 mg fast delivery, and resource use hypertension in african americans buy generic indapamide canada. Preliminary investigation of a group intervention for siblings of pediatric cancer patients blood pressure medication you can take while pregnant discount indapamide 2.5 mg buy on-line. Sibling adaptation to childhood cancer collaborative study: cross cultural aspects arteria cerebral media order 1.5 mg indapamide otc. Brief report: empathy and psychological adjustment in siblings of children with cancer. The siblings of childhood cancer patients need early support: a follow up study over the first year. Psychosocial impacts of a camping experience for children with cancer and their siblings. Caring for family members with chronic physical illness: a critical review of caregiver literature. Psychological distress in long-term survivors of solid tumors diagnoses in childhood. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors. One month after diagnosis: quality of life, coping and previous functioning in siblings of children with cancer. Behavior changes exhibited by siblings of pediatric oncology patients: a comparison between maternal and sibling description. Culturally diverse children and adolescents: assessment, diagnosis, and treatment. Guidelines for the pediatric cancer center and the role of such centers in diagnosis and treatment. Evidence-based assessment, intervention and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment. A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment. Feasibility and preliminary outcomes from a pilot study of a brief psychological intervention for families of children newly diagnosed with cancer. The feasibility of conducting a randomized clinical trial of an intervention for parent/caregivers of children newly diagnosed with cancer. Chapter 46 Ethical Considerations in Pediatric Oncology Steven Joffe Jennifer Kesselheim Susan B. Shurin the notion of an ethical dilemma is familiar to those who care for or conduct research with children with cancer. We want to avoid burdensome interventions at the end of life while keeping open any possibility that the child may recover. Understanding of and commitment to ethical values and principles are central to professionalism in medical and research practice. The fundamental principles of professional practice include the primacy of patient welfare, autonomy, and social justice. Importantly, increasing evidence suggests that professionalism can be taught and learned, and that it must be a core component at all stages of medical education. By analogy, many adults are models of moral integrity yet know little of Mill and Kant. Ethics is also a 2nd-order discipline, an attempt to understand moral behavior and to use this understanding to guide and justify the best course of action when confronted with ethical challenges. This chapter is an attempt to use systematic analysis to shed light on ethical questions that arise in pediatric oncology. In what follows, we concentrate on selected areas relevant to clinicians and investigators caring for and conducting research with children with cancer. We begin with discussions of informed consent and of the ethics of human subjects research. This is followed by comments on confidentiality, genetic testing, and ethics in endof-life care. We contend that, in every area of pediatric oncology, professionalism requires attention to the ethical dimensions of clinical and research practice. Informed Consent Few areas of bioethics have evolved as dramatically over the past 50 years as has the discussion of the rights and responsibilities of patients and their physicians. For centuries, both physicians and patients assumed that the physician knew what was best, and therefore bore responsibility for medical decisions. The Hippocratic Oath directed physicians to "follow that system of regimen which, according to my ability and judgment, I consider for the benefit of my patients. As the scientific basis of medical practice has solidified, both physicians and patients have come to expect an evidence base for recommendations and decisions. As a result, the locus of authority for medical decisions has shifted decisively to the patient. In some instances, this means that patients are burdened with decisions when a modicum of paternalism or at least of wise guidance might be helpful. Respect for persons, or respect for autonomy, is operationalized in the practice of informed consent. Scattered legal cases from the 1700s to the early 1900s emphasized the need for consent-usually without considering how or whether the patient became informed- and viewed infractions of the consent requirement as tantamount to battery. Since the mid-1900s, legal cases have developed the requirement for informed consent, and consequently for sufficient disclosure by the physician about the relevant facts. Consent to treatment evolved as a legal doctrine, as patients successfully brought malpractice actions for violations of consent. First, many conversations and decisions take place primarily between clinicians and parents, with increasing involvement of children as they mature. Second, the remarkable proportion of patients cared for within trials demands understanding of both clinical and research consent. Fourth, the protracted nature of cancer treatment underscores the point that informed consent is a process-an ongoing conversation between the patient, responsible relatives or caregivers, and a team of physicians and nurses-rather than a discrete event. We start with the simplest case-the competent adult deciding about nonresearch clinical care-before addressing consent in pediatrics. Competence is a legal term that specifies if a person has authority to manage her own affairs in a particular domain of life. Capacity denotes the perceptual, cognitive, and communicative ability to perform a particular task. It reflects a clinical rather than a legal judgment, and therefore falls within the domain of physicians and others with appropriate clinical expertise. For example, although the average older teen may have capacity to make most medical decisions, she will generally be presumed legally incompetent in most jurisdictions. Disclosure Disclosure refers to the information that must be communicated to the patient, including: (a) the nature and purpose of the proposed treatment; (b) the foreseeable risks and discomforts; (c) the potential benefits; and (d) available alternatives. Although this requirement seems onerous, any reasonable interpretation recognizes the need for selectivity in the amount and type of information shared. Three standards are available to guide physicians in deciding what information to present to patients. Two are used by courts to determine whether physicians have met their disclosure requirements. Under the professional standard, the physician must provide the information that a reasonable physician would disclose in similar circumstances. Under the reasonable-person standard, the physician must provide all the information that a reasonable decision maker would want to know. A third standard, the subjective standard, is an ethical ideal that has no specific correlate in the law. Under this standard, the clinician should provide the information that is material not just for a reasonable person, but for this particular person. For example, even if most patients would not wish to know of the rare risk of mild peripheral neuropathy from a chemotherapeutic, this information might be of crucial importance to a professional pianist. Meeting this standard requires that the physician know the patient well enough to anticipate that such information would be subjectively relevant. Failures of disclosure undermine the validity of informed consent through willful or unintentional deception. Distortion or omission of key facts deprives patients of the information they need to make decisions. Some commentators and courts have carved out a "therapeutic privilege" exception to disclosure requirements. This exception opens the door wide open to inappropriate paternalism and therefore should be sparingly invoked. Understanding It is easier to determine what a clinician has disclosed than what a patient has understood. Courts have therefore generally looked to evidence of disclosure rather than of understanding to judge the adequacy of consent. Studies have shown, for example, that individuals will choose different treatments, depending on whether the risks are presented as the probability of success or of failure. Indeed, not attempting to persuade in these circumstances would be ethically inappropriate. Coercion differs from persuasion in that it involves the use of credible threats to influence decisions. Involving legitimate outside authorities may be justified when the situation requires examination for broader societal concerns, but such threats should only be used when efforts at persuasion have been made repeatedly and have failed. Decision Because of the legal view of informed consent, many clinicians see consent as signature on the bottom of a form. The transitive verb to consent (him or her) has emerged in hospital jargon to describe this activity as another procedure performed upon the patient. Informed Consent, Surrogate Authorization, and Incompetent Adults the model of autonomous consent is such a powerful paradigm for medical decision making that it has overwhelmed other possible models. The law has sought to define ways in which partially or fully incapacitated patients can exercise these rights indirectly via surrogates. The substituted-judgment standard seeks decisions based on actual values and preferences that patients had before becoming incompetent. One type of directive, the living will, allows patients to specify the extent to which they would like to have life-sustaining medical treatments provided should they develop specific medical problems while incompetent. Living wills have proved problematic, however; few people complete them, individuals have difficulty predicting their wishes in serious and unfamiliar circumstances, it is difficult to articulate those preferences, and clinicians and surrogates do not reliably act on them. The Patient Self-Determination Act of 1990 requires hospitals in the United States to inquire whether adult patients currently have an advance directive, and to give them an opportunity to create one if they do not. Most of the sentinel legal cases involving noncompetent adults involved patients who never were expected to regain capacity. The goal is to respect the former autonomy of adults; with children, the challenge is to protect their future autonomy. In making difficult decisions for young children, the best interests standard provides the best available guidance about the appropriate treatment. In many circumstances, physicians should also solicit patient assent when developmentally appropriate. In cases involving emancipated or mature minors with adequate decision-making capacity, or when otherwise permitted by law, physicians should seek informed consent directly from patients. Also, as we discuss in the following text, the weight of the assent requirement in childhood cancer research is controversial. Involvement of Children in Consenting to Treatment and to Research Participation Few topics in pediatric bioethics are as challenging as the concept of "assent" by children to undergo medical procedures or participate in research. Helping the patient achieve a developmentally appropriate awareness of her condition; 2. Status-based emancipation is generally justified by the fact that the parents no longer have responsibility for or authority over the teen, whereas condition-based emancipation is thought to serve the public health by encouraging teens to seek treatment for sensitive conditions. Minors emancipated by virtue of status can generally give or withhold consent in any treatment setting, whereas those with a specified condition may only be granted the right to make independent decisions P. An important corollary of emancipation is that the minor generally has the right to decide who (including her parents) may receive access to her medical record. It is important to recognize that emancipation does not necessarily imply mature decision-making facility (indeed, some reasons for emancipation, such as pregnancy, may suggest the converse). As a result, efforts to assist emancipated minors in making reasonable decisions are often ethically appropriate. Mature minors are not emancipated, but nevertheless may have a legally enforceable decision making role based on their capacity to give informed consent. If a minor evidences such capacity in connection with a proposed treatment, including the ability to understand its nature and risks, he or she may have the legal right to consent to or refuse treatment. Although variability among children and families precludes the identification of agebased rules, practical as well as ethical considerations favor disclosing the diagnosis to patients, while working with parents to inform children in a sensitive and individualized manner. When an Older Child Dissents from Medically Necessary Diagnostic or Therapeutic Procedures Directly related to the issue of assent for treatment is the management of active dissent, primarily by adolescents, from unwanted treatment. Active dissent from research participation is more likely to be respected than dissent from standard therapy, unless participation in research is likely to bring the child substantial benefit that is not available otherwise. There is no simple way to resolve the dilemmas that result when adolescents refuse recommended therapy. Assistance from consultants such as psychosocial clinicians, clergy, ethics committees, or legal counsel should be sought in difficult cases. Parental Refusal of Therapy on Cultural or Other Grounds Not all families subscribe to Western allopathic approaches to medicine. Furthermore, alternative approaches to healing are widely employed by patients and families either exclusively or in combination with allopathic treatments. Both groups within Western cultures and individuals and groups who have immigrated may come in conflict with the broadly accepted values enunciated in this chapter. The resulting clashes of cultures tend to be more dramatic in cases involving children than adults. A striking example of such culture clash involving a Hmong family was described in 1998. One of the hallmarks of good ethical decision making is that similar cases should be decided similarly: if the clinicians would seek a court order to treat a U.

The lesions are granulomas and consist of an inner core of necrosis (where the yeast and pseudohyphae can be found) surrounded by a ring of inflammatory cells and an outer ring of fibrosis pulmonary hypertension xray purchase 2.5 mg indapamide fast delivery. These imaged lesions change over time and with treatment and resolution may become calcified (an important end point of therapy) hypertension ppt cheap indapamide 2.5 mg buy. This illustrates the variable appearances of candida abscesses on ultrasound studies at different times in the same patient blood pressure 9555 indapamide 2.5 mg purchase online. Note the acoustical shadow posterior to the lesion prehypertension erectile dysfunction indapamide 1.5 mg order online, caused by attenuation of the sound beam (arrowheads) blood pressure yoga poses buy 1.5 mg indapamide free shipping. Blood cultures may be negative prior to the diagnosis of hepatic candidiasis and are almost invariably negative upon recovery from neutropenia. The diagnosis of hepatic candidiasis is based on a high index of suspicion and ideally should be confirmed with liver biopsy. Other conditions that may radiologically resemble hepatic candidiasis include the underlying or new neoplastic disease. Hepatic tissue may be obtained by a small midline open incision in children and by laparoscopy in adolescents and adults. The detection of the Candida enolase antigen and D-arabinitol in blood has been employed as an adjunctive tool for diagnosing invasive candidiasis, including hepatic candidiasis. Historically, long courses of treatment are necessary, with the average duration of D-AmB administered approximately 6 to 12 months. Experimental data and several encouraging reports indicate that fluconazole also has favorable efficacy in the treatment of hepatosplenic candidiasis in patients in whom amphotericin B has failed to control the infection or who have had serious amphotericin B­related toxicities. However, failures of fluconazole in this setting have also been described, suggesting that caution should be exercised in closely monitoring patients with hepatosplenic candidiasis. A reasonable approach is to treat children initially with amphotericin B and after the patient is afebrile or has response of lesions to change therapy to fluconazole at 6 mg/kg/day. This infection in patients with cancer can be treated successfully under careful observation through repeated courses of chemotherapy-induced neutropenia without progression of hepatosplenic candidiasis or breakthrough fungemia. Premature discontinuation of therapy may lead to recurrence of symptoms and progression of lesions. Anorectal Infections Anorectal infections present as perianal fissures, perianal cellulitis, and perirectal infections. Anal fissures are the most common cause of anorectal infections in neutropenic patients. Presenting as painful linear tears in the mucocutaneous integrity of the anal orifice, uncomplicated anal fissures can be successfully treated with an initial antibacterial regimen targeting aerobic gram-negative bacilli, such as ceftazidime or cefepime. Broadening coverage to antianaerobic activity for these superficial but painful fissures usually is not necessary unless there is evidence of concomitant perianal cellulitis. If symptoms of perianal fissure do not improve within 48 hours, broadening of initial antibacterial empirical therapy to include anaerobes is warranted. Perianal cellulitis presents as pain, tenderness, and erythema extending beyond the anal orifice. Extension of tenderness and erythema into the surrounding soft tissue may involve anaerobic flora. Hence, the presence of perianal cellulitis warrants the addition of antianaerobic coverage, such as metronidazole, to ceftazidime or cefepime, or the substitution of the initial empirical antimicrobial by a carbapenem or piperacillin-tazobactam. The overall incidence of perianal cellulitis has decreased in recent years, presumably because of the early use of empirical antibiotics when granulocytopenic patients become febrile. Nonetheless, the risk for perianal cellulitis remains, especially for patients in the high-risk category, those with chronic (>7 days) and profound (<100 cells/mm3) granulocytopenia. Predisposing factors include perianal mucositis caused by chemotherapy or localized radiotherapy, hemorrhoids, anal fissures, and any type of rectal manipulation. Accordingly, constipation should be avoided, because passage of hard stool promotes the formation of anal fissures and increases the risk of perianal infection. The most common pathogens in perianal cellulitis are aerobic gram-negative bacilli. Because of the potential involvement of anaerobic organisms, antibiotic coverage must include a specific antianaerobic agent such as metronidazole or clindamycin in addition to broad-spectrum aerobic coverage. A diagnosis of perianal fissure and perianal cellulitis should be pursued at the first complaints of tenderness. Additional supportive measures include sitz baths three or four times daily, stool softeners, a low-bulk diet, and avoidance of unnecessary rectal manipulation, especially repetitive digital examinations. Surgical intervention should be restricted to those cases that demonstrate the development of an abscess or progressive involvement of the ischiorectal fossa despite optimal antimicrobial therapy. Developing as the result of disruption of the rectal mucosa and extension of infection into the pelvic perirectal tissues, the diagnosis is suspected in patients with intractable perianal cellulitis; development of perianal fistulas, suggesting a tract between the skin and deeper pelvic tissues; and the presence of persistent fever. Therapeutic approaches to perirectal abscesses include antianaerobic coverage and timely surgical or percutaneous catheter drainage of collections. The responsible pathogens are most commonly those colonizing the adjacent skin: coagulase-positive and coagulase-negative staphylococci, Corynebacterium species, and Propionibacterium acnes; rarely, they are gram-negative bacilli. Meningitis Infectious meningitis in cancer patients is uncommon but associated with significant morbidity and mortality. In a retrospective series of 40 pediatric cancer patients with meningitis, recent neurosurgical manipulation was found to be the most common risk factor in 65% of cases. The pathogens causing infection were similar to those that are commonly associated with bacteremia in this patient population, including gram-positive organisms (S. Neutropenia at presentation was the primary risk factor for death related to meningitis in this series. Encephalitis Various viral, bacterial, parasitic, fungal, and rickettsial agents can be associated with encephalitis or encephalomyelitis. For example, patients with humoral immune abnormalities, especially hypogammaglobulinemia, may have a chronic encephalitis caused by poliovirus or echovirus. Protein levels are usually elevated, and the glucose level characteristically remains within the normal range except for a decreased level in mumps infection. For the cancer patient with focal neurologic deficits or altered mentation, it is important to separate infectious, metabolic, toxic, and neoplastic causes. Definitive diagnosis requires demonstration of the parasite within tissue sections. Pyrimethamine combined with sulfadiazine, with the addition of folinic acid to reduce pyrimethamine-induced myelotoxicity, is considered standard treatment of active toxoplasmosis. For immunodeficient patients, therapy should be continued for 4 to 6 weeks after the resolution of all clinical symptoms and signs. Other agents combined with pyrimethamine, such as atovaquone, dapsone, or the newer macrolides, may also be effective in treatment of toxoplasmosis in immunocompromised hosts. The organisms most often causing brain abscesses in immunocompetent and immunosuppressed patients are typically aerobic and anaerobic bacteria derived from the oral cavity. However, because pediatric oncology patients are immunosuppressed, nocardiosis and invasive fungal infections also rank high in the differential diagnosis for brain abscess in this population. Early evaluation and specific diagnosis are crucial in the management of brain abscess, because effective antimicrobial or neurosurgical therapy is available. Diagnosis is commonly made by radiographic demonstration of a localized mass and followed by an open or closed procedure to aspirate or resect the localized lesion. Only four (7%) had a bacterial brain abscess, and one patient had cerebral toxoplasmosis. Aspergillus species accounted for 60% of isolates and one-third were caused by Candida species. In a neutropenic patient, urine culture of a single organism should prompt antibiotic intervention whether or not the patient is symptomatic. The presence or absence of leukocytes in the urine should not be used as a diagnostic criterion in neutropenic hosts. Differentiation between colonization and tissue invasion is particularly difficult for fungal pathogens. Fungal colonization is especially prevalent among patients with indwelling urinary catheters and those receiving broad-spectrum antimicrobial therapy. Unlike the typical situation with bacterial pathogens, in which clinical signs and symptoms are apparent, fungal invasion of the genitourinary tract may be insidious. Heavily colonized bladders or superficial bladder infections manifested by persistence of positive urine cultures despite removal of predisposing factors may be effectively treated by fluconazole, which is highly concentrated in the urine. If the patient is not receiving azole prophylaxis or empirical therapy, fluconazole should be used as initial therapy in neutropenic patients. If the infection represents an emergence through azole therapy, amphotericin B, which can achieve fungicidal concentrations in the urine, should be used. Bladder pain and gross hematuria may occur suddenly and can be very difficult to control. Urinary tract infections may be localized, but in some cases they precede a disseminated adenovirus infection. Several bacterial and fungal skin and soft-tissue infections have distinctive clinical features. The lesions of ecthyma gangrenosum range from the more typical necrotic ulcerative lesion and black eschars to vesiculobullous or diffuse macular lesions that may progress to the more classical lesions. Other aerobic gram-negative bacilli that may cause lesions of ecthyma gangrenosum include Aeromonas species and S. Toxin-producing group A streptococci tend to cause localized foci of serpiginous erythema. With primary muscle infection by Clostridium species, fever, pain, tenderness, and edema of an extremity develop initially and are followed later by dusky cutaneous lesions. Notably, examination of the extent of these clostridial cutaneous lesions may markedly underestimate the degree of primary deep fascial and muscle infections until the time of surgery. Aspergillus species and Zygomycetes are angioinvasive and also may cause cutaneous lesions of ecthyma gangrenosum as the result of direct inoculation; hematogenously disseminated lesions of aspergillosis tend to cause deep dermal nonulcerative nodular lesions. Although staphylococcal paronychia is part of the differential diagnosis, fusarial paronychia is reported to occur in neutropenic patients who are already receiving broad-spectrum antibiotics. Hospital water and water distribution systems, such as showers, may be the source of nosocomial fusarial paronychial infections. Scabies infestation may present as papules, excoriations, or vesicles located particularly in the interdigital spaces and on the palms and soles, face, neck, and scalp. A severe clinical variant of scabies, called Norwegian or crusted scabies, occurs in immunodeficient patients and is characterized by widespread, hyperkeratotic, and crusted lesions. As these lesions contain heavy burdens of mites and their eggs, Norwegian scabies is highly contagious. Lindane 1% lotion has been the standard treatment for scabies, although it is not recommended for young children because it is percutaneously absorbed and may cause neurologic side effects. Permethrin 5% cream is recommended for children as it is poorly absorbed and may be more effective than lindane. The antiparasitic agent, ivermectin, has been shown to be highly effective in curing both routine cases and Norwegian scabies P. Unless recognized, these conditions may lead to the inappropriate use of antibiotics. Maculopapular eruptions due to drugs are commonly encountered particularly in relation to -lactam antibiotics. Erythema multiforme and Stevens-Johnson syndrome may also occur, especially as a reaction to sulfonamides. Cutaneous lesions in oncology patients may be paraneoplastic manifestations of the primary neoplastic process but simulate infectious processes. For example, Sweet syndrome is associated with hematologic malignancies and is characterized by fever and nodular or ulcerative skin lesions. Biopsy of the lesions of Sweet syndrome may be deceptive as they histologically may demonstrate a dense neutrophilic infiltrate of the papillary and reticular dermis. Occasionally, tumor infiltration of the skin by a chloroma, lymphoid malignancy, melanoma, or metastatic tumor may ulcerate and become superinfected usually by Staphylococcus species or by water-borne organisms, such as P. Prevention of Infection in Children with Cancer In a multitude of clinical trials investigating the efficacy of various measures to prevent or reduce infection, the most important antiinfective measure identified has been the simplest: careful handwashing practices. However, no method has stood out as singularly effective and each has both promise and problems. Preventing the Acquisition of New Organisms Because most of the organisms responsible for infections in patients with cancer are derived from the endogenous flora, and almost half of this flora is acquired from the hospital environment, much attention has been directed toward preventing the acquisition of potential pathogens. Although epidemiologic studies have, for the most part, investigated nonimmunocompromised patients, they also suggest that transmission from inanimate sources often requires a human vector. Therefore, the most efficacious and practical intervention that can be performed is adherence to strict handwashing precautions. The easiest way to enforce such a policy is to educate the child and parents to disallow contact with anyone who has neglected to wash his or her hands. A second maneuver to decrease the acquisition of new organisms is to maintain a cooked diet during periods of granulocytopenia, with avoidance of fresh fruits and vegetables and nonprocessed diary products, because these foods are naturally contaminated with gram-negative bacteria, especially E. In medical centers where Aspergillus species and Fusarium species are a significant P. Hence, there is no compelling reason to enforce this policy, particularly because the extra expense, time consumption, and inconvenience are not balanced by a beneficial effect. A sterile environment is created in a clean-air room with constant positive-pressure airflow. It is maintained by an aggressive program of surface decontamination and sterilization of all objects that enter the room and by an intensive regimen to disinfect the patient, including oral nonabsorbable antibiotics, skin antiseptics, antibiotic sprays and ointments, and a low-microbial diet. The total protective environment reduces the number of infections in profoundly granulocytopenic patients. However, a total protective environment is expensive, and because of the improvement in treating established infections, it does not offer a survival advantage to patients. Total protective isolation is not necessary for the routine care of cancer patients. Modifications of the approach are used, on occasion, for patients undergoing allogeneic bone marrow transplantation and for patients who are likely to experience periods of 30 or more days of profound neutropenia. This technique has not been especially valuable because the agents used are unpalatable and poorly tolerated, making compliance a significant problem, especially among patients receiving emetogenic chemotherapy.

Patients with impaired cellular immunity are at particularly increased risk for legionellosis blood pressure chart pulse 2.5 mg indapamide with amex. Legionella species are commonly found in water sources and may be found in the hospital environment blood pressure blurry vision indapamide 2.5 mg buy overnight delivery, leading to nosocomial acquisition blood pressure kidney damage 1.5 mg indapamide purchase otc. Legionella pneumonia in immunosuppressed pediatric patients is heralded by abrupt onset of nonspecific symptoms such as fever heart attack marlie grace order indapamide 1.5 mg overnight delivery, malaise blood pressure lab report best indapamide 1.5 mg, anorexia, lethargy, and headache. A nonproductive cough develops in most patients; chest pain, dyspnea, diarrhea, and neurologic symptoms may be prominent features. Because this organism grows optimally on buffered charcoal yeast agar, the clinical microbiology laboratory should be alerted when Legionella pneumonia is suspected. Erythromycin or azithromycin given for 3 weeks is the treatment of choice in pediatric patients. Fluoroquinolones, such as ciprofloxacin and levofloxacin, are also effective in the treatment of legionellosis but should be employed only in pediatric patients who are refractory to or intolerant of the macrolide antibiotics. Nocardia species, particularly Nocardia asteroides, also present most frequently as a localized or nodular pulmonary infiltrate,257 although miliary and microcavitary patterns have been reported but are distinctly less common. Diagnosis depends on positive cultures or histopathologic demonstration of tissue invasion by the organisms. Among the noninfectious causes of localized pulmonary infiltrates in a nonneutropenic patient to be considered in the differential diagnosis are progression of the underlying malignancy, an atelectatic segment of lung (potentially caused by narrowing of the airway by adjacent or endobronchial tumor), intraalveolar hemorrhage, radiation injury, and pulmonary embolus. Localized Pulmonary Infiltrates in Neutropenic Patients Among the opportunistic pathogens that cause localized infiltrates in neutropenic patients are gram-positive or gram-negative bacteria, fungi, and viruses, as well as those pathogens listed in the section on localized infiltrates in nonneutropenic patients Table 40. Bacterial pathogens predominate in patients with neutropenia lasting less than 10 to 14 days. Patients with longer periods of neutropenia and those in certain clinical settings. Unless the clinical presentation suggests otherwise, it is appropriate to initiate a 48- to 72-hour trial of broadspectrum antibiotics before proceeding to an invasive diagnostic procedure. If the patient has stabilized or improved by 72 hours, a 10- to 14-day course of treatment is necessary. Invasive aspergillosis is the most frequently encountered cause of a localized pulmonary infiltrate in patients with protracted neutropenia, particularly if the patient already is receiving broad-spectrum antibiotics. Depending on the patient population, several studies have demonstrated a sensitivity ranging from 50% to 95% and specificity ranging from 87% to 99% for diagnosis of invasive aspergillosis. A common scenario for development of invasive aspergillosis in pediatric oncology is that of a profoundly and persistently neutropenic patient who develops localized, progressive pulmonary infiltrates while receiving broad-spectrum antibiotics. The incidence of pulmonary infections caused by Aspergillus species has increased and has been observed in clusters in various hospitals. Despite this propensity for widespread disease, blood cultures are virtually never positive. Based on the compelling findings of the international randomized trial demonstrating that voriconazole conferred a significant benefit of survival and overall therapeutic response, primary therapy of invasive pulmonary aspergillosis should be initiated with voriconazole. Recent plasma pharmacokinetic studies demonstrate that plasma clearance of voriconazole in pediatric patients is significantly greater than that observed in adults,137 prompting a recommendation for higher dosages, preferably at 7 mg/kg every 12 hours. These compounds may be particularly important in patients receiving concomitant nephrotoxic agents, such as aminoglycosides, cyclosporin, and foscarnet. Even with potent pharmacologic intervention, the most important prognosticator of a successful outcome is recovery from neutropenia. Subsequent cycles of chemotherapy-induced neutropenia may result in recurrence of Aspergillus pneumonia unless antifungal therapy is continued during these periods of immunosuppression. Surgical resection should be considered in the following situations: hemoptysis from a single cavitary lesion; progression of a solitary lesion despite antifungal therapy; and infiltration into contiguous structures, including pericardium, great vessels, esophagus, or chest wall while receiving antifungal therapy. Other filamentous fungi, such as Scedosporium species, Fusarium species, dematiaceous molds, and the Zygomycetes, especially Rhizopus species, can cause pulmonary infiltrates that are similar to those associated with Aspergillus. Diagnosis requires documentation of tissue invasion, particularly to distinguish zygomycosis from other infections. However, successful outcomes have been achieved in oncology patients with either voriconazole for scedosporiosis and fusariosis or with amphotericin B against fusariosis. Among the noninfectious causes of diffuse pulmonary infiltrates in patients with cancer are antineoplastic agents. Pneumocystis jiroveci (carinii) is an important treatable cause of diffuse pulmonary infiltrates in pediatric oncology patients. However, both neutropenic and nonneutropenic patients are at risk for severe infection from P. However, patient-to-patient transmission has been suggested by reports of nosocomial clusters of cases. Radiographic examination usually reveals bilateral diffuse alveolarinterstitial infiltrates, often originating at the hilum and extending peripherally. Rarely, the chest radiograph is atypical, ranging from normal to a lobar or nodular infiltrate. Orally administered atovaquone is another option for patients who are not acutely ill. The recommendation for adults is for 40-mg prednisone (or the equivalent corticosteroid) twice daily for the first 5 days of treatment, 40 mg once daily for the next 5 days, and then 20 mg once daily for 11 days, for a total treatment course of 21 days. An estimated equivalent for children is 1 mg/kg twice daily for the first 5 days, 1 mg/kg daily for the next 5 days, and 0. Mycoplasma pneumoniae and Chlamydia pneumoniae can cause diffuse pulmonary infiltrates and severe disease in immunocompromised children. However, because ganciclovir therapy has significant myelotoxicity, primarily causing granulocytopenia, patients should be monitored carefully. Foscarnet is an appropriate alternative to ganciclovir, particularly in those at risk for myelotoxicity or who are intolerant of or refractory to ganciclovir. Although no randomized controlled studies have addressed the utility of ribavirin in immunocompromised cancer patients, it may be appropriate to extrapolate from existing data in other pediatric populations that suggest that there may be a benefit of this therapy. Therapeutic options for pneumonia due to these viruses are limited and are associated with a high rate of morbidity and mortality. Very few individuals younger than 30 years have protective levels of cross-reactive neutralizing antibodies against the H1N1 virus. Viridans streptococcal infections in neutropenic patients are more likely to cause a fulminant septic event in comparison with nonneutropenic patients who are more likely to have endocarditis. Rightsided endovascular infections are more likely with the increased use of indwelling venous access catheters. These latter pathogens are particularly difficult to eradicate, and morbidity and mortality remain discouragingly high. The clinical manifestations of endocarditis in immunosuppressed patients are similar to those in immunocompetent patients. Nonspecific complaints of fever, chills, malaise, fatigue, night sweats, and weight loss are common, but these complaints are nondescript, and the degree of diagnostic specificity that may be ascribed to them is slight. In most instances, the diagnosis must be made on the basis of the physical and laboratory evaluations. Ultimately, the diagnosis is confirmed by the isolation of an organism from multiple blood cultures. The complications of endovascular infection in immunocompromised patients are similar to those described for patients without cancer. Valvular insufficiency resulting in congestive heart failure, emboli, and renal failure are the most serious. The differential diagnosis of pericarditis includes radiation therapy, neoplastic infiltration, and several major infectious etiologies (bacterial, viral, and fungal). Aspergillosis pericarditis is a particularly devastating complication in immunosuppressed oncology patients. Initial management requires percutaneous pericardial drainage and systemic antifungal therapy. Pericardial resection is usually required for definitive eradication of infection. Normally, it acts as a mechanical barrier, but it can be disrupted by tumor invasion or by damage from chemotherapy or radiotherapy. The mucosal ulceration induced by these treatments offers a potential site for bacterial, fungal, viral, and parasitic infection. Infections of the Oral Cavity Oropharyngeal candidiasis ("thrush") is the most common oral mucosal infection encountered in the immunosuppressed oncology patient. The lesions of oropharyngeal candidiasis usually appear as whitish plaques with slightly raised indurated borders. This infection is easily controlled in most cases by topical antifungal agents, such as clotrimazole troches or nystatin suspension. If there is no response to topical therapy, fluconazole at doses of 2 to 3 mg/kg/day is highly effective for the treatment and prevention of oropharyngeal candidiasis. However, intraoral lesions may be nondescript, often ulcerative, and can be confused with the stomatotoxicity usually attributed to chemotherapy. Diagnosis may be confirmed by rapid shell vial culture (requiring 24 to 48 hours) by a positive fluorescent-antibody reaction. The severity of the local tissue involvement, inflammation, and eschar formation has deleterious consequences, causing discomfort and also serving as a nidus for bacterial and fungal superinfections. Acyclovir (750 mg/m2/day divided every 8 hours or 5 mg/kg every 8 hours) is the preferred treatment because of its infrequent toxicity, ease of administration, and documented efficacy in reducing the duration of viral shedding and shortening the time to healing. Periodontal disease (including gingivitis and periodontitis) is especially problematic among adults, and the incidence of periodontal disease in the general population increases with age. However, periodontal disease may be found among pediatric cancer patients and is related to the adverse effects of the antineoplastic therapy on the host defense mechanisms normally operative in the oral mucosa. The periodontium is the most common site, and cultures of infected sites reveal mixed aerobic and anaerobic flora. Esophageal Infections Clinically overt esophageal infection may result from infectious or noninfectious causes. A syndrome clinically identical to infectious esophagitis occurs in patients who have received extensive chest wall or mediastinal irradiation, or it may result from the severe mucosal toxicity that is associated with certain chemotherapeutic regimens. Patients most often present with subacute onset of retrosternal burning chest pain, dysphagia, and odynophagia. Fungal, viral, and bacterial organisms can all cause an infectious esophagitis in the immunocompromised host. In nonneutropenic patients, esophagitis is most commonly caused by chemical irritation of the distal esophagus by refluxed gastric contents, as may be associated with chemotherapy-induced emesis. These patients are best managed with judicious use of antacids, histamine antagonists, or omeprazole. If the nonneutropenic patient has a persistent esophageal discomfort, esophagoscopy with brushings for culture and biopsy should be performed. Chemotherapy-induced mucositis, neutropenia, mediastinal radiation, and gastroesophageal reflux are important risk factors for esophageal candidiasis. The absence of oral lesions cannot be used to discount the presence of esophageal candidiasis in neutropenic patients. Although esophagoscopy with mucosal biopsy is the most definitive method for establishing a diagnosis, this may not be feasible, practical, or safe in many children. Accordingly, an empirical approach is often warranted in children with suspected esophageal candidiasis. Initial therapy with fluconazole is often effective; however, failure to symptomatically respond promptly is an indication for empirical amphotericin B or an echinocandin for treatment of possible azole-resistant Candida species. Echinocandins have been extensively studied experimentally and clinically in treatment of esophageal candidiasis due to fluconazole-susceptible and fluconazole-resistant Candida species. If the patient symptomatically responds to acyclovir, antiviral therapy should be given for 7 days. For example, obstructive lesions may be caused by primary or metastatic cancer, cholangitis or a conjugated hyperbilirubinemia may be caused by extrahepatic biliary obstruction by tumor, and chronic abdominal pain or diarrheal syndromes may be secondary to bowel wall infiltration by malignant disease or infection. Intraabdominal pain must be expeditiously evaluated with a thorough physical examination. Repetitive rectal examinations must not be performed in the neutropenic patient, because bacteremia and local infection may result. Appropriate studies include routine hematologic and serum chemistry values, amylase, total and direct bilirubin, and flat and upright abdominal radiographs. Invasive diagnostic or radiographic procedures such as barium enema and endoscopy should be avoided in the neutropenic patient. Typhlitis or neutropenic colitis is a necrotizing infection of the cecum restricted almost entirely to cancer patients. Patients most often present with subacute or acute onset of right lower quadrant abdominal pain and tenderness, which frequently becomes generalized over several hours, with fever, diarrhea, and prostration. As fever may be absent early in the course of neutropenic colitis, the presence of abdominal pain in a neutropenic patient should prompt the administration of empirical antibacterial therapy for aerobic and anaerobic pathogens. The etiologic agents responsible for typhlitis include anaerobes and gram-negative bacilli, especially P. Optimal management initially involves supportive care, including nasogastric suction, adequate fluid replacement, and adjustment of antimicrobial therapy to cover resistant gram-negative and anaerobic species. However, if typhlitis develops in a patient who has diarrhea and has received previous antibacterial therapy, then ceftazidime or cefepime plus metronidazole is the logical choice. Although the cecum is the most common site of infection, abnormalities may extend beyond this region. Aggressive surgical intervention to resect necrotic bowel may be beneficial for a subset of patients, and the timing of such intervention is critical. A high index of suspicion is necessary because of the occurrence of similar abdominal symptoms in oncology patients receiving chemotherapy or periabdominal radiation. Oncology patients with diarrhea with or without fever and abdominal pain should be evaluated with routine stool cultures and a C. Oral vancomycin is reserved for patients intolerant of or refractory to metronidazole. The use of vancomycin as first-line therapy is discouraged because of concern about emergence of resistant gram-positive organisms.

Discount 1.5 mg indapamide. TELMA-AM BLOOD PRESSURE BP BP KI MEDICINEBLOOD PRESSURE KESE CONTROL KARE.

References

• Archie JP Jr. Mathematic coupling of data: a common source of error. J Appl Physiol. 1980;193:296-303.
• Hudak J, Berger Z, Varga L. An assay for serum vitamin-B12 and for intrinsic factor antibody type I by means of hog intrinsic factor. Acta Med Acad Sci Hung 1980;37:157.
• Kawauchi A, Yoneda K, Fujito A, et al: Oncologic outcome of hand-assisted laparoscopic radical nephrectomy, Urology 69(1):53n56, 2007.
• Baillie GS, et al. Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci U S A 2003;100:940-945.